Resistance to the macrocyclic lactone moxidectin is mediated in part by membrane transporter P-glycoproteins: Implications for control of drug resistant parasitic nematodes

被引:37
作者
Bygarski, Elizabeth E. [1 ]
Prichard, Roger K. [2 ]
Ardelli, Bernadette F. [1 ]
机构
[1] Brandon Univ, Dept Biol, Brandon, MB R7A 6A9, Canada
[2] McGill Univ, Inst Parasitol, Ste Anne De Bellevue, PQ H9X 3V9, Canada
来源
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE | 2014年 / 4卷 / 03期
基金
加拿大创新基金会; 加拿大自然科学与工程研究理事会;
关键词
Caenorhabditis; Moxidectin; ABC systems; P-glycoprotein; Inhibition; Motility; Pharyngeal pumping; CAENORHABDITIS-ELEGANS; IVERMECTIN RESISTANCE; HAEMONCHUS-CONTORTUS; ABC TRANSPORTERS; CHLORIDE CHANNEL; GENE-EXPRESSION; SENSITIVITY; VERAPAMIL; AVERMECTINS; DISPOSITION;
D O I
10.1016/j.ijpddr.2014.06.002
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Our objective was to determine if the resistance mechanism to moxidectin (MOX) is similar of that to ivermectin (IVM) and involves P-glycoproteins (PGPs). Several Caenorhabditis elegans strains were used: an IVM and MOX sensitive strain, 13 PGP deletion strains and the IVM-R strain which shows synthetic resistance to IVM (by creation of three point mutations in genes coding for alpha-subunits of glutamate gated chloride channels [GluCls]) and cross-resistance to MOX. These strains were used to compare expression of PGP genes, measure motility and pharyngeal pumping phenotypes and evaluate the ability of compounds that inhibit PGP function to potentiate sensitivity or reverse resistance to MOX. The results suggest that C. elegans may use regulation of PGPs as a response mechanism to MOX. This was indicated by the over-expression of several PGPs in both drug sensitive and IVM-R strains and the significant changes in phenotype in the IVM-R strain in the presence of PGP inhibitors. However, as the inhibitors did not completely disrupt expression of the phenotypic traits in the IVM-R strain, this suggests that there likely are multiple avenues for MOX action that may include receptors other than GluCls. If MOX resistance was mediated solely by GluCls then exposure of the IVM-R strain to PGP inhibitors should not have affected sensitivity to MOX. Targeted gene deletions showed that protection of C. elegans against MOX involves complex mechanisms and depends on the PGP gene family, particularly PGP-6. While the results presented are similar to others using IVM, there were some important differences observed with respect to PGPs which may play a role in the disparities seen in the characteristics of resistance to IVM and MOX. The similarities are of concern as parasites resistant to IVM show some degree but not complete cross-resistance to MOX; this could impact nematodes that are resistant to IVM. (C) 2014 The Authors. Published by Elsevier Ltd.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 38 条
  • [1] Inventory and analysis of ATP-binding cassette (ABC) systems in Brugia malayi
    Ardelli, B. F.
    Stitt, L. E.
    Tompkins, J. B.
    [J]. PARASITOLOGY, 2010, 137 (08) : 1195 - 1212
  • [2] Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin
    Ardelli, Bernadette F.
    Prichard, Roger K.
    [J]. VETERINARY PARASITOLOGY, 2013, 191 (3-4) : 264 - 275
  • [3] A comparison of the effects of ivermectin and moxidectin on the nematode Caenorhabditis elegans
    Ardelli, Bernadette F.
    Stitt, Laurel E.
    Tompkins, Jeffrey B.
    Prichard, Roger K.
    [J]. VETERINARY PARASITOLOGY, 2009, 165 (1-2) : 96 - 108
  • [4] Ardelli BF, 2008, J NEMATOL, V40, P290
  • [5] CHEMOSENSORY NEURONS WITH OVERLAPPING FUNCTIONS DIRECT CHEMOTAXIS TO MULTIPLE CHEMICALS IN C-ELEGANS
    BARGMANN, CI
    HORVITZ, HR
    [J]. NEURON, 1991, 7 (05) : 729 - 742
  • [6] Cystic canal mutants in Caenorhabditis elegans are defective in the apical membrane domain of the renal (excretory) cell
    Buechner, M
    Hall, DH
    Bhatt, H
    Hedgecock, EM
    [J]. DEVELOPMENTAL BIOLOGY, 1999, 214 (01) : 227 - 241
  • [7] Campbell W. C., 1989, IVERMECTIN ABAMECTIN
  • [8] CHIN KV, 1990, CELL GROWTH DIFFER, V1, P361
  • [9] CLONING OF AN AVERMECTIN-SENSITIVE GLUTAMATE-GATED CHLORIDE CHANNEL FROM CAENORHABDITIS-ELEGANS
    CULLY, DF
    VASSILATIS, DK
    LIU, KK
    PARESS, PS
    VANDERPLOEG, LHT
    SCHAEFFER, JM
    ARENA, JP
    [J]. NATURE, 1994, 371 (6499) : 707 - 711
  • [10] Microbial drug discovery: 80 years of progress
    Demain, Arnold L.
    Sanchez, Sergio
    [J]. JOURNAL OF ANTIBIOTICS, 2009, 62 (01) : 5 - 16